Skip to main content

Advertisement

Log in

Quantitative pharmacokinetic analysis of high-temporal-resolution dynamic contrast-enhanced MRI to differentiate the normal-appearing pituitary gland from pituitary macroadenoma

  • Original Article
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the usefulness of high-temporal-resolution dynamic contrast-enhanced (DCE) MRI and quantitative pharmacokinetic analysis to differentiate the normal-appearing pituitary gland from a pituitary macroadenoma.

Materials and methods

Twenty-seven patients with macroadenomas underwent preoperative DCE-MRI with a temporal resolution of 5 s using compressed sensing to obtain pharmacokinetic parameters. Two independent observers localized the normal-appearing pituitary gland on post-contrast T1-weighted images before and after referring to the corresponding Ktrans maps. Agreements between the localizations and intraoperative findings were evaluated using the kappa statistics. The Mann–Whitney U test was used to compare the pharmacokinetic parameters of the normal-appearing pituitary gland and adenoma.

Results

For both observers, the agreement between the MRI-based localization and the intraoperative findings increased after referring to the Ktrans maps (observer 1, 0.930–1; observer 2, 0.636–0.855). The normal-appearing pituitary gland had significantly higher Ktrans [/min] (1.50 ± 0.80 vs 0.58 ± 0.49, P < 0.0001), kep [/min] (3.19 ± 1.29 vs 2.15 ± 1.18, P = 0.0049), and ve (0.43 ± 0.15 vs 0.25 ± 0.17, P = 0.0003) than adenoma.

Conclusion

High-temporal-resolution DCE-MRI and quantitative pharmacokinetic analysis help accurately localize the normal-appearing pituitary gland in patients with macroadenomas. The normal-appearing pituitary gland was characterized by higher Ktrans, kep, and ve than macroadenoma.

Condensed abstract

Dynamic contrast-enhanced MRI with high-temporal-resolution using compressed sensing was used for quantitative pharmacokinetic analysis of pituitary macroadenomas. An observer study, the use of Ktrans maps improved accuracy in localizing the normal-appearing pituitary gland. As compared to an adenoma, the normal-appearing pituitary gland had significantly higher Ktrans, kep, and ve values.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ciric I, Ragin A, Baumgartner C, Pierce D. Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery. 1997;40:225–37.

    Article  CAS  Google Scholar 

  2. Agam MS, Zada G. Complications associated With transsphenoidal pituitary surgery: review of the literature. Neurosurgery. 2018;65:69–73. https://doi.org/10.1093/neuros/nyy160.

    Article  PubMed  Google Scholar 

  3. Fatemi N, Dusick JR, Mattozo C, McArthur DL, Cohan P, Boscardin J, et al. Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery. 2008;63:709–19. https://doi.org/10.1227/01.NEU.0000325725.77132.90.

    Article  PubMed  Google Scholar 

  4. Miki Y, Matsuo M, Nishizawa S, Kuroda Y, Keyaki A, Makita Y, et al. Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging. Radiology. 1990;177:35–8.

    Article  CAS  Google Scholar 

  5. Lee HB, Kim ST, Kim HJ, Kim KH, Jeon P, Byun HS, et al. Usefulness of the dynamic gadolinium-enhanced magnetic resonance imaging with simultaneous acquisition of coronal and sagittal planes for detection of pituitary microadenomas. Eur Radiol. 2012;22:514–8. https://doi.org/10.1007/s00330-011-2291-3.

    Article  PubMed  Google Scholar 

  6. Petrillo A, Fusco R, Petrillo M, Granata V, Bianco F, Di Marzo M, et al. DCE-MRI time-intensity curve visual inspection to assess pathological response after neoadjuvant therapy in locally advanced rectal cancer. Jpn J Radiol. 2018;36:611–21. https://doi.org/10.1007/s11604-018-0760-1.

    Article  CAS  PubMed  Google Scholar 

  7. Lloyd RV, Scheithauer BW, Kuroki T, Vidal S, Kovacs K, Stefaneanu L. Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas. Endocr Pathol. 1999;10:229–35.

    Article  CAS  Google Scholar 

  8. Jasek E, Furgal-Borzych A, Lis GJ, Litwin JA, Rzepecka-Wozniak E, Trela F. Microvessel density and area in pituitary microadenomas. Endocr Pathol. 2009;20:221–6. https://doi.org/10.1007/s12022-009-9091-1.

    Article  CAS  PubMed  Google Scholar 

  9. Sourbron SP, Buckley DL. On the scope and interpretation of the Tofts models for DCE-MRI. Magn Reson Med. 2011;66:735–45. https://doi.org/10.1002/mrm.22861.

    Article  PubMed  Google Scholar 

  10. Zhang N, Zhang L, Qiu B, Meng L, Wang X, Hou BL. Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas. J Magn Reson Imaging. 2012;36:355–63. https://doi.org/10.1002/jmri.23675.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Lu S, Gao Q, Yu J, Li Y, Cao P, Shi H, et al. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor. Eur J Radiol. 2016;85:1722–7. https://doi.org/10.1016/j.ejrad.2016.07.005.

    Article  PubMed  Google Scholar 

  12. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223–32.

    Article  CAS  Google Scholar 

  13. Jia ZZ, Gu HM, Zhou XJ, Shi JL, Li MD, Zhou GF, et al. The assessment of immature microvascular density in brain gliomas with dynamic contrast-enhanced magnetic resonance imaging. Eur J Radiol. 2015;84:1805–9. https://doi.org/10.1016/j.ejrad.2015.05.035.

    Article  PubMed  Google Scholar 

  14. Lustig M, Donoho D, Pauly JM. Sparse MRI: The application of compressed sensing for rapid MR imaging. Magn Reson Med. 2007;58:1182–95.

    Article  Google Scholar 

  15. Rofsky NM, Lee VS, Laub G, Pollack MA, Krinsky GA, Thomasson D, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology. 1999;212:876–84.

    Article  CAS  Google Scholar 

  16. Osamura RY, Lopes MBS, Grossman A, Kontogeorgos G, Trouillas J. Tumor of the pituitary gland. In: Lloyd RV, Osamura RY, Kloppel G, Rosai J, editors. WHO Classification of Tumours of Endocrine Organs. 4th ed. Lyon: IARC; 2017. p. 11–64.

    Google Scholar 

  17. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420–8.

    Article  CAS  Google Scholar 

  18. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.

    Article  CAS  Google Scholar 

  19. Rossi Espagnet MC, Bangiyev L, Haber M, Block KT, Babb J, Ruggiero V, et al. High-resolution DCE-MRI of the pituitary gland using radial k-space acquisition with compressed sensing reconstruction. AJNR Am J Neuroradiol. 2015;36:1444–9. https://doi.org/10.3174/ajnr.A4324.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Zhai J, Zheng W, Zhang Q, Wu J, Zhang X. Pharmacokinetic analysis for the differentiation of pituitary microadenoma subtypes through dynamic contrast-enhanced magnetic resonance imaging. Oncol Lett. 2019;17:4237–44. https://doi.org/10.3892/ol.2019.10083.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Kamimura K, Nakajo M, Yoneyama T, Fukukura Y, Fujio S, Goto Y, et al. Assessment of microvessel perfusion of pituitary adenomas: a feasibility study using turbo spin-echo-based intravoxel incoherent motion imaging. AJNR Am J Neuroradiol. 2019. https://doi.org/10.1007/s00330-019-06443-x.

    Article  Google Scholar 

  22. Zhao M, Guo LL, Huang N, Wu Q, Zhou L, Zhao H, et al. Quantitative analysis of permeability for glioma grading using dynamic contrast-enhanced magnetic resonance imaging. Oncol Lett. 2017;14:5418–26. https://doi.org/10.3892/ol.2017.6895.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Zou HH, Yu J, Wei Y, Wu JF, Xu Q. Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2019;49:885–93. https://doi.org/10.1002/jmri.26254.

    Article  PubMed  Google Scholar 

  24. Sahoo P, Frankel P, Ressler J, Gutova M, Annala AJ, Badie B, et al. Early changes in tumor perfusion from T1-weighted dynamic contrast-enhanced MRI following neural stem cell-mediated therapy of recurrent high-grade glioma correlate with overall survival. Stem Cells Int. 2018. https://doi.org/10.1155/2018/5312426.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Sen R, Sen C, Pack J, Block KT, Golfinos JG, Prabhu V, et al. Role of high-resolution dynamic contrast-enhanced MRI with golden-angle radial sparse parallel reconstruction to identify the normal pituitary gland in patients with macroadenomas. AJNR Am J Neuroradiol. 2017;38:1117–21. https://doi.org/10.3174/ajnr.A5244.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This paper was presented at the 78th annual meeting of the Japan Radiological Society (JRS) in Yokohama, Japan, in 2019. The authors wish to thank the staff of Kagoshima University Hospital for their support. The authors would like to thank Enago (www.enago.jp) for the English language review.

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kiyohisa Kamimura.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Written informed consent was waived by the Institutional Review Board.

Ethical statement

The study protocol was approved by the Ethics Committee of Kagoshima University Graduate School of Medical and Dental Sciences (approval no. 180255) and was conducted in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kamimura, K., Nakajo, M., Yoneyama, T. et al. Quantitative pharmacokinetic analysis of high-temporal-resolution dynamic contrast-enhanced MRI to differentiate the normal-appearing pituitary gland from pituitary macroadenoma . Jpn J Radiol 38, 649–657 (2020). https://doi.org/10.1007/s11604-020-00942-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-020-00942-4

Keywords

Navigation